News

Horizon 2020

Comac Medical has been selected to participate in Horizon 2020 Program. Please click here for more information regarding the program.

Share:
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...
The Bulgarian Drug Agency has announced reduced time periods for consideration of clinical trials on medicinal products for...